快速检索:        
    
在线办公系统
在线期刊
下载专区
排行榜
友情链接
扫描微信二维码,获取更多信息
周利红,殷佩浩,王炎,刘宁宁,李琦,范忠泽.健脾解毒方对幽门螺杆菌诱发胃癌过程微血管密度及环氧合酶表达的影响[J].中国中西医结合杂志,2011,31(5):647-652
健脾解毒方对幽门螺杆菌诱发胃癌过程微血管密度及环氧合酶表达的影响
Effect of Jianpi Jiedu Recipe on Microvessel Density and Cyclooxygenase-2 Expression in Helicobacter pylori Induced Gastric Cancer
免费下载全文  查看/发表评论  下载PDF阅读器
  
DOI:
中文关键词:  幽门螺杆菌  胃癌  血管新生  微血管密度  环氧合酶-2  健脾解毒方
英文关键词:Helicobacter pylori  gastric cancer  angiogenesis  microvessel density  cyclooxygenase-2  Jianpi Jiedu Recipe
基金项目:国家自然科学基金资助项目(No.30600844,81072955);上海市卫生局科研项目(No.2010019);上海市教委青年基金资助项目(No.09JW44);上海市重点学科资助项目(No.S30302);上海市普陀区科委资助创新项目
作者单位
周利红 上海中医药大学附属普陀医院肿瘤科
上海中医药大学中西医结合肿瘤介入研究所 
殷佩浩 上海中医药大学附属普陀医院肿瘤科
上海中医药大学中西医结合肿瘤介入研究所 
王炎 上海中医药大学附属普陀医院肿瘤科
上海中医药大学中西医结合肿瘤介入研究所 
刘宁宁 上海中医药大学附属普陀医院肿瘤科
上海中医药大学中西医结合肿瘤介入研究所 
李琦 上海中医药大学附属普陀医院肿瘤科
上海中医药大学中西医结合肿瘤介入研究所 
范忠泽 上海中医药大学附属普陀医院肿瘤科
上海中医药大学中西医结合肿瘤介入研究所 
摘要点击次数: 1353
全文下载次数: 1394
中文摘要:
      目的探讨健脾解毒方在幽门螺杆菌(Helicobacter pylori,H.pylori)长期感染诱发C57BL/6小鼠胃癌过程中对微血管密度(microvessel density,MVD)和环氧合酶-2(COX-2)的调控作用,为其治疗H.pylori相关性胃病提供实验依据。方法用H.pylori标准株悉尼株(H.pyloriSS1)灌胃的方法建立H.pylori感染C57BL/6小鼠诱发胃癌动物模型,分为对照组、模型组、健脾解毒方低剂量组和健脾解毒方高剂量组,每组40只小鼠。给药72周后处死小鼠,免疫组化法检测各组小鼠胃黏膜MVD的变化;实时荧光定量PCR法和免疫组化法检测各组小鼠胃黏膜COX-2mRNA和蛋白的表达。结果对照组、模型组、健脾解毒方低、高剂量组胃癌的发生率分别为0、22.2%、11.1%和10.0%;胃黏膜MVD分别为(2.50±1.54)、(18.56±2.62)、(14.61±3.60)和(7.39±1.75)个/cm2,模型组MVD较对照组明显增高(P<0.01),健脾解毒方低、高剂量组MVD显著降低(P<0.01)。模型组COX-2mRNA和蛋白表达较对照组均明显增加(P<0.01);健脾解毒方低、高剂量组均可降低其表达,并呈现剂量依赖关系。结论 H.pylori感染可增加C57BL/6小鼠胃黏膜MVD,促进COX-2的表达,可能在H.pylori诱导的胃癌发生中起到促进作用;健脾解毒方可减少小鼠胃黏膜MVD,抑制COX-2的表达,这可能是其防治胃癌的重要机制之一。
英文摘要:
      Objective To investigate the regulatory effect of Jianpi Jiedu Recipe (JJR) on the microvessel density (MVD) and cyclooxygenase-2 (COX-2) in long-term infection of Helicobacter pylori induced gastric cancer of C57BL/6 mice,thus providing experimental bases for its treatment of the H. pylori correlated gastropathy. Methods C57BL/6 mouse gastric cancer model induced by H. pylori infection was established by gastrogavage of H. pylori standard strain SS1. Mice were divided into the control group,the model group,low dose JJR group,and the high dose JJR group,40 in each group. Mice were sacrificed after 72-week medication. Changes of the gastric mucosa MVD of mice in each group were detected by immunohistochemical method. Expressions of COX-2 mRNA and protein were detected by Real-time fluorescent quantitative polymerase chain reaction and immunohistochemical method. Results The occurrence rate of gastric cancer in the control group,the model group,the low dose JJR group,and the high dose JJR group was 0,22.2%,11.1%,and 10.0%,respectively. The gastric mucosa MVD (number/cm2) of mice in each group was 2.50±1.54,18.56±2.62,14.61±3.60,and 7.39±1.75,respectively. The gastric mucosa MVD in the model group increased more obviously than that in the control group (P<0.01). The gastric mucosa MVD significantly decreased in the low dose JJR group and the high dose JJR group (P<0.01). Expressions of COX-2 mRNA and protein in the model group increased more obviously than those in the control group (P<0.01). Low dose JJR and high dose JJR could decrease their expressions in a dose dependent manner. Conclusions H. pylori infection could increase the gastric mucosa MVD of C57BL/6 mice and promote COX-2 expressions,which might play a promoting effect in the incidence of H.pylori induced gastric cancer. JJR could decrease the gastric mucosa MVD and inhibit COX-2 expressions,which might be one of its important mechanisms of preventing and treating gastric cancer.
关闭